Julie Martin

Bio:

Julie is an industry veteran of nearly two decades who leads Scimega as CEO. Her passion for Scimega’s business and team stems from knowing its expert oncology clinical development services add distinct value to industry stakeholders at a time when it’s needed most. Julie leverages her in depth industry expertise and business acumen to secure the company’s long term success.

As President & CEO Julie equates that success with setting a clear vision for the organization’s continued sense of purpose. Her leadership, and collaboration with the managing Board of Directors, combined ensure the business excellence upon which Scimega has built its reputation.

Julie plays a vital role in promoting Scimega’s expertise and showcasing Canada’s attributes as a formidable partner in global oncology drug development with an evolving Lean methodology.